National and regional differences in meningococcal vaccine recommendations for individuals at an increased risk of meningococcal disease

• Egile Nagusiak: Cynthia Burman (Egilea), Jamie Findlow (Egilea), Helen S. Marshall (Egilea), Marco A.P. Safadi (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction Invasive meningococcal disease (IMD) is a severe, life-threatening condition caused by infection with Neisseria meningitidis. Currently available vaccines offer protection against the five most common meningococcal disease-causing serogroups and include monovalent and quadrivalent conju...